These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 16026839)

  • 1. Complement and diseases: defective alternative pathway control results in kidney and eye diseases.
    Zipfel PF; Heinen S; Józsi M; Skerka C
    Mol Immunol; 2006 Jan; 43(1-2):97-106. PubMed ID: 16026839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of defective complement control in hemolytic uremic syndrome.
    Zipfel PF; Misselwitz J; Licht C; Skerka C
    Semin Thromb Hemost; 2006 Mar; 32(2):146-54. PubMed ID: 16575689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.
    Servais A; Frémeaux-Bacchi V; Lequintrec M; Salomon R; Blouin J; Knebelmann B; Grünfeld JP; Lesavre P; Noël LH; Fakhouri F
    J Med Genet; 2007 Mar; 44(3):193-9. PubMed ID: 17018561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of complement in physiology and pathology].
    Klaska I; Nowak JZ
    Postepy Hig Med Dosw (Online); 2007; 61():167-77. PubMed ID: 17410057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis.
    Licht C; Fremeaux-Bacchi V
    Thromb Haemost; 2009 Feb; 101(2):271-8. PubMed ID: 19190809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune forms of thrombotic microangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles.
    Skerka C; Licht C; Mengel M; Uzonyi B; Strobel S; Zipfel PF; Józsi M
    Mol Immunol; 2009 Sep; 46(14):2801-7. PubMed ID: 19640589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models.
    Saunders RE; Abarrategui-Garrido C; Frémeaux-Bacchi V; Goicoechea de Jorge E; Goodship TH; López Trascasa M; Noris M; Ponce Castro IM; Remuzzi G; Rodríguez de Córdoba S; Sánchez-Corral P; Skerka C; Zipfel PF; Perkins SJ
    Hum Mutat; 2007 Mar; 28(3):222-34. PubMed ID: 17089378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammatory statesthe examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degeneration.
    Richards A; Kavanagh D; Atkinson JP
    Adv Immunol; 2007; 96():141-77. PubMed ID: 17981206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor H family proteins and human diseases.
    Józsi M; Zipfel PF
    Trends Immunol; 2008 Aug; 29(8):380-7. PubMed ID: 18602340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic deficiency of complement factor H in a patient with age-related macular degeneration and membranoproliferative glomerulonephritis.
    Montes T; Goicoechea de Jorge E; Ramos R; Gomà M; Pujol O; Sánchez-Corral P; Rodríguez de Córdoba S
    Mol Immunol; 2008 May; 45(10):2897-904. PubMed ID: 18336910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies in haemolytic uraemic syndrome (HUS).
    Skerka C; Józsi M; Zipfel PF; Dragon-Durey MA; Fremeaux-Bacchi V
    Thromb Haemost; 2009 Feb; 101(2):227-32. PubMed ID: 19190803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H.
    Pickering MC; Cook HT; Warren J; Bygrave AE; Moss J; Walport MJ; Botto M
    Nat Genet; 2002 Aug; 31(4):424-8. PubMed ID: 12091909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement dysfunction in hemolytic uremic syndrome.
    Zipfel PF; Skerka C
    Curr Opin Rheumatol; 2006 Sep; 18(5):548-55. PubMed ID: 16896298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains.
    Pickering MC; de Jorge EG; Martinez-Barricarte R; Recalde S; Garcia-Layana A; Rose KL; Moss J; Walport MJ; Cook HT; de Córdoba SR; Botto M
    J Exp Med; 2007 Jun; 204(6):1249-56. PubMed ID: 17517971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel C3 mutation causing increased formation of the C3 convertase in familial atypical hemolytic uremic syndrome.
    Sartz L; Olin AI; Kristoffersson AC; Ståhl AL; Johansson ME; Westman K; Fremeaux-Bacchi V; Nilsson-Ekdahl K; Karpman D
    J Immunol; 2012 Feb; 188(4):2030-7. PubMed ID: 22250080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons from functional and structural analyses of disease-associated genetic variants in the complement alternative pathway.
    Rodríguez de Córdoba S; Harris CL; Morgan BP; Llorca O
    Biochim Biophys Acta; 2011 Jan; 1812(1):12-22. PubMed ID: 20837143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemolytic uremic syndrome: a factor H mutation (E1172Stop) causes defective complement control at the surface of endothelial cells.
    Heinen S; Józsi M; Hartmann A; Noris M; Remuzzi G; Skerka C; Zipfel PF
    J Am Soc Nephrol; 2007 Feb; 18(2):506-14. PubMed ID: 17229916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The simple design of complement factor H: Looks can be deceiving.
    Alexander JJ; Quigg RJ
    Mol Immunol; 2007 Jan; 44(1-3):123-32. PubMed ID: 16919753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The complement fitness factor H: role in human diseases and for immune escape of pathogens, like pneumococci.
    Zipfel PF; Hallström T; Hammerschmidt S; Skerka C
    Vaccine; 2008 Dec; 26 Suppl 8():I67-74. PubMed ID: 19388168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [From gene to disease; the haemolytic uraemic syndrome can be caused by mutations in regulating factors of the alternative route of the complement system].
    Geelen JM; Klasen IS; van den Heuvel LP; Monnens LA
    Ned Tijdschr Geneeskd; 2007 Jan; 151(3):185-8. PubMed ID: 17288344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.